|
V74607
|
Pegloxenatide (PEX 168) |
2420483-82-3 |
Pegloxenatide is a glucagon-like peptide-1 receptor (GLP-1 RA) agonist. |
|
V74575
|
Pemvidutide |
2538014-94-5 |
Pemvidutide is a dual GLP-1R/GCGR agonist that causes significant reductions in body weight, liver fat, and serum lipids. |
|
V74599
|
Survodutide (BI 456906) |
2805997-46-8 |
Survodutide is a glucagon and glucagon-like peptide 1 (GLP-1) receptor (GLP Receptor) agonist. |
|
V76464
|
Survodutide TFA (BI 456906 TFA) |
|
Survodutide (TFA) is a glucagon and glucagon-like peptide 1 (GLP-1) receptor (GLP Receptor) agonist. |
|
V76413
|
Tirzepatide hydrochloride (LY3298176 hydrochloride) |
|
Tirzepatide HCl (LY3298176 HCl) is a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors with potential for use in type 2 diabetes research. |
|
V81592
|
Tirzepatide TFA (LY3298176 TFA) |
|
Tirzepatide TFA (LY3298176 TFA) is a glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist/activator with potential for use in type 2 diabetes research. |
|
V74598
|
V-0219 hydrochloride |
2922283-73-4 |
V-0219 HCl (Compound 9) is an orally bioactive glucagon-like peptide-1 receptor (GLP-1R) PAM (positive allosteric modulator). |